Global Viral Vector CDMO Services Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AAV
1.2.3 Lentivirus
1.2.4 Adenovirus
1.2.5 HSV
1.2.6 Others
1.3 Market by Application
1.3.1 Global Viral Vector CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Vaccine Development
1.3.3 Gene Therapy
1.3.4 Academic Scientific Research Institution
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector CDMO Services Market Perspective (2020-2031)
2.2 Global Viral Vector CDMO Services Growth Trends by Region
2.2.1 Global Viral Vector CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector CDMO Services Market Dynamics
2.3.1 Viral Vector CDMO Services Industry Trends
2.3.2 Viral Vector CDMO Services Market Drivers
2.3.3 Viral Vector CDMO Services Market Challenges
2.3.4 Viral Vector CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector CDMO Services Players by Revenue
3.1.1 Global Top Viral Vector CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Viral Vector CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Viral Vector CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector CDMO Services Revenue
3.4 Global Viral Vector CDMO Services Market Concentration Ratio
3.4.1 Global Viral Vector CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector CDMO Services Revenue in 2024
3.5 Global Key Players of Viral Vector CDMO Services Head office and Area Served
3.6 Global Key Players of Viral Vector CDMO Services, Product and Application
3.7 Global Key Players of Viral Vector CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector CDMO Services Breakdown Data by Type
4.1 Global Viral Vector CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector CDMO Services Forecasted Market Size by Type (2026-2031)
5 Viral Vector CDMO Services Breakdown Data by Application
5.1 Global Viral Vector CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector CDMO Services Market Size (2020-2031)
6.2 North America Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector CDMO Services Market Size by Country (2020-2025)
6.4 North America Viral Vector CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector CDMO Services Market Size (2020-2031)
7.2 Europe Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector CDMO Services Market Size by Country (2020-2025)
7.4 Europe Viral Vector CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector CDMO Services Market Size (2020-2031)
9.2 Latin America Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Viral Vector CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector CDMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Viral Vector CDMO Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Viral Vector CDMO Services Introduction
11.2.4 Lonza Revenue in Viral Vector CDMO Services Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Viral Vector CDMO Services Introduction
11.3.4 Catalent Revenue in Viral Vector CDMO Services Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River Viral Vector CDMO Services Introduction
11.4.4 Charles River Revenue in Viral Vector CDMO Services Business (2020-2025)
11.4.5 Charles River Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Viral Vector CDMO Services Introduction
11.5.4 Merck Revenue in Viral Vector CDMO Services Business (2020-2025)
11.5.5 Merck Recent Development
11.6 SK pharmteco
11.6.1 SK pharmteco Company Details
11.6.2 SK pharmteco Business Overview
11.6.3 SK pharmteco Viral Vector CDMO Services Introduction
11.6.4 SK pharmteco Revenue in Viral Vector CDMO Services Business (2020-2025)
11.6.5 SK pharmteco Recent Development
11.7 Oxford Biomedica
11.7.1 Oxford Biomedica Company Details
11.7.2 Oxford Biomedica Business Overview
11.7.3 Oxford Biomedica Viral Vector CDMO Services Introduction
11.7.4 Oxford Biomedica Revenue in Viral Vector CDMO Services Business (2020-2025)
11.7.5 Oxford Biomedica Recent Development
11.8 AGC Biologics（MolMed）
11.8.1 AGC Biologics（MolMed） Company Details
11.8.2 AGC Biologics（MolMed） Business Overview
11.8.3 AGC Biologics（MolMed） Viral Vector CDMO Services Introduction
11.8.4 AGC Biologics（MolMed） Revenue in Viral Vector CDMO Services Business (2020-2025)
11.8.5 AGC Biologics（MolMed） Recent Development
11.9 Gene Universal
11.9.1 Gene Universal Company Details
11.9.2 Gene Universal Business Overview
11.9.3 Gene Universal Viral Vector CDMO Services Introduction
11.9.4 Gene Universal Revenue in Viral Vector CDMO Services Business (2020-2025)
11.9.5 Gene Universal Recent Development
11.10 Polyplus (Sartorius)
11.10.1 Polyplus (Sartorius) Company Details
11.10.2 Polyplus (Sartorius) Business Overview
11.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Introduction
11.10.4 Polyplus (Sartorius) Revenue in Viral Vector CDMO Services Business (2020-2025)
11.10.5 Polyplus (Sartorius) Recent Development
11.11 CCRM
11.11.1 CCRM Company Details
11.11.2 CCRM Business Overview
11.11.3 CCRM Viral Vector CDMO Services Introduction
11.11.4 CCRM Revenue in Viral Vector CDMO Services Business (2020-2025)
11.11.5 CCRM Recent Development
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Details
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector CDMO Services Business (2020-2025)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.13 Biovian
11.13.1 Biovian Company Details
11.13.2 Biovian Business Overview
11.13.3 Biovian Viral Vector CDMO Services Introduction
11.13.4 Biovian Revenue in Viral Vector CDMO Services Business (2020-2025)
11.13.5 Biovian Recent Development
11.14 Miltenyi Bioindustry
11.14.1 Miltenyi Bioindustry Company Details
11.14.2 Miltenyi Bioindustry Business Overview
11.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Introduction
11.14.4 Miltenyi Bioindustry Revenue in Viral Vector CDMO Services Business (2020-2025)
11.14.5 Miltenyi Bioindustry Recent Development
11.15 Aldevron
11.15.1 Aldevron Company Details
11.15.2 Aldevron Business Overview
11.15.3 Aldevron Viral Vector CDMO Services Introduction
11.15.4 Aldevron Revenue in Viral Vector CDMO Services Business (2020-2025)
11.15.5 Aldevron Recent Development
11.16 Takara Bio
11.16.1 Takara Bio Company Details
11.16.2 Takara Bio Business Overview
11.16.3 Takara Bio Viral Vector CDMO Services Introduction
11.16.4 Takara Bio Revenue in Viral Vector CDMO Services Business (2020-2025)
11.16.5 Takara Bio Recent Development
11.17 Yposkesi
11.17.1 Yposkesi Company Details
11.17.2 Yposkesi Business Overview
11.17.3 Yposkesi Viral Vector CDMO Services Introduction
11.17.4 Yposkesi Revenue in Viral Vector CDMO Services Business (2020-2025)
11.17.5 Yposkesi Recent Development
11.18 Genezen
11.18.1 Genezen Company Details
11.18.2 Genezen Business Overview
11.18.3 Genezen Viral Vector CDMO Services Introduction
11.18.4 Genezen Revenue in Viral Vector CDMO Services Business (2020-2025)
11.18.5 Genezen Recent Development
11.19 GenScript ProBio
11.19.1 GenScript ProBio Company Details
11.19.2 GenScript ProBio Business Overview
11.19.3 GenScript ProBio Viral Vector CDMO Services Introduction
11.19.4 GenScript ProBio Revenue in Viral Vector CDMO Services Business (2020-2025)
11.19.5 GenScript ProBio Recent Development
11.20 EurekaBio
11.20.1 EurekaBio Company Details
11.20.2 EurekaBio Business Overview
11.20.3 EurekaBio Viral Vector CDMO Services Introduction
11.20.4 EurekaBio Revenue in Viral Vector CDMO Services Business (2020-2025)
11.20.5 EurekaBio Recent Development
11.21 Obio Technology
11.21.1 Obio Technology Company Details
11.21.2 Obio Technology Business Overview
11.21.3 Obio Technology Viral Vector CDMO Services Introduction
11.21.4 Obio Technology Revenue in Viral Vector CDMO Services Business (2020-2025)
11.21.5 Obio Technology Recent Development
11.22 GeneSail Biotech
11.22.1 GeneSail Biotech Company Details
11.22.2 GeneSail Biotech Business Overview
11.22.3 GeneSail Biotech Viral Vector CDMO Services Introduction
11.22.4 GeneSail Biotech Revenue in Viral Vector CDMO Services Business (2020-2025)
11.22.5 GeneSail Biotech Recent Development
11.23 VectorBuilder
11.23.1 VectorBuilder Company Details
11.23.2 VectorBuilder Business Overview
11.23.3 VectorBuilder Viral Vector CDMO Services Introduction
11.23.4 VectorBuilder Revenue in Viral Vector CDMO Services Business (2020-2025)
11.23.5 VectorBuilder Recent Development
11.24 WuXi ATU
11.24.1 WuXi ATU Company Details
11.24.2 WuXi ATU Business Overview
11.24.3 WuXi ATU Viral Vector CDMO Services Introduction
11.24.4 WuXi ATU Revenue in Viral Vector CDMO Services Business (2020-2025)
11.24.5 WuXi ATU Recent Development
11.25 Ubrigene
11.25.1 Ubrigene Company Details
11.25.2 Ubrigene Business Overview
11.25.3 Ubrigene Viral Vector CDMO Services Introduction
11.25.4 Ubrigene Revenue in Viral Vector CDMO Services Business (2020-2025)
11.25.5 Ubrigene Recent Development
11.26 Porton Biologics
11.26.1 Porton Biologics Company Details
11.26.2 Porton Biologics Business Overview
11.26.3 Porton Biologics Viral Vector CDMO Services Introduction
11.26.4 Porton Biologics Revenue in Viral Vector CDMO Services Business (2020-2025)
11.26.5 Porton Biologics Recent Development
11.27 Pharmaron
11.27.1 Pharmaron Company Details
11.27.2 Pharmaron Business Overview
11.27.3 Pharmaron Viral Vector CDMO Services Introduction
11.27.4 Pharmaron Revenue in Viral Vector CDMO Services Business (2020-2025)
11.27.5 Pharmaron Recent Development
11.28 PackGene Biotechnology
11.28.1 PackGene Biotechnology Company Details
11.28.2 PackGene Biotechnology Business Overview
11.28.3 PackGene Biotechnology Viral Vector CDMO Services Introduction
11.28.4 PackGene Biotechnology Revenue in Viral Vector CDMO Services Business (2020-2025)
11.28.5 PackGene Biotechnology Recent Development
11.29 Hillgene
11.29.1 Hillgene Company Details
11.29.2 Hillgene Business Overview
11.29.3 Hillgene Viral Vector CDMO Services Introduction
11.29.4 Hillgene Revenue in Viral Vector CDMO Services Business (2020-2025)
11.29.5 Hillgene Recent Development
11.30 Asymchem
11.30.1 Asymchem Company Details
11.30.2 Asymchem Business Overview
11.30.3 Asymchem Viral Vector CDMO Services Introduction
11.30.4 Asymchem Revenue in Viral Vector CDMO Services Business (2020-2025)
11.30.5 Asymchem Recent Development
11.31 Exthera
11.31.1 Exthera Company Details
11.31.2 Exthera Business Overview
11.31.3 Exthera Viral Vector CDMO Services Introduction
11.31.4 Exthera Revenue in Viral Vector CDMO Services Business (2020-2025)
11.31.5 Exthera Recent Development
11.32 Flash Therapeutics
11.32.1 Flash Therapeutics Company Details
11.32.2 Flash Therapeutics Business Overview
11.32.3 Flash Therapeutics Viral Vector CDMO Services Introduction
11.32.4 Flash Therapeutics Revenue in Viral Vector CDMO Services Business (2020-2025)
11.32.5 Flash Therapeutics Recent Development
11.33 VIVEBiotech
11.33.1 VIVEBiotech Company Details
11.33.2 VIVEBiotech Business Overview
11.33.3 VIVEBiotech Viral Vector CDMO Services Introduction
11.33.4 VIVEBiotech Revenue in Viral Vector CDMO Services Business (2020-2025)
11.33.5 VIVEBiotech Recent Development
11.34 FinVector
11.34.1 FinVector Company Details
11.34.2 FinVector Business Overview
11.34.3 FinVector Viral Vector CDMO Services Introduction
11.34.4 FinVector Revenue in Viral Vector CDMO Services Business (2020-2025)
11.34.5 FinVector Recent Development
11.35 uBriGene
11.35.1 uBriGene Company Details
11.35.2 uBriGene Business Overview
11.35.3 uBriGene Viral Vector CDMO Services Introduction
11.35.4 uBriGene Revenue in Viral Vector CDMO Services Business (2020-2025)
11.35.5 uBriGene Recent Development
11.36 Eurogentec
11.36.1 Eurogentec Company Details
11.36.2 Eurogentec Business Overview
11.36.3 Eurogentec Viral Vector CDMO Services Introduction
11.36.4 Eurogentec Revenue in Viral Vector CDMO Services Business (2020-2025)
11.36.5 Eurogentec Recent Development
11.37 VGXI
11.37.1 VGXI Company Details
11.37.2 VGXI Business Overview
11.37.3 VGXI Viral Vector CDMO Services Introduction
11.37.4 VGXI Revenue in Viral Vector CDMO Services Business (2020-2025)
11.37.5 VGXI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Viral Vector CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AAV
Table 3. Key Players of Lentivirus
Table 4. Key Players of Adenovirus
Table 5. Key Players of HSV
Table 6. Key Players of Others
Table 7. Global Viral Vector CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Viral Vector CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Viral Vector CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Viral Vector CDMO Services Market Share by Region (2020-2025)
Table 11. Global Viral Vector CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Viral Vector CDMO Services Market Share by Region (2026-2031)
Table 13. Viral Vector CDMO Services Market Trends
Table 14. Viral Vector CDMO Services Market Drivers
Table 15. Viral Vector CDMO Services Market Challenges
Table 16. Viral Vector CDMO Services Market Restraints
Table 17. Global Viral Vector CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Viral Vector CDMO Services Market Share by Players (2020-2025)
Table 19. Global Top Viral Vector CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector CDMO Services as of 2024)
Table 20. Ranking of Global Top Viral Vector CDMO Services Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Viral Vector CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Viral Vector CDMO Services, Headquarters and Area Served
Table 23. Global Key Players of Viral Vector CDMO Services, Product and Application
Table 24. Global Key Players of Viral Vector CDMO Services, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Viral Vector CDMO Services Revenue Market Share by Type (2020-2025)
Table 28. Global Viral Vector CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Viral Vector CDMO Services Revenue Market Share by Type (2026-2031)
Table 30. Global Viral Vector CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Viral Vector CDMO Services Revenue Market Share by Application (2020-2025)
Table 32. Global Viral Vector CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Viral Vector CDMO Services Revenue Market Share by Application (2026-2031)
Table 34. North America Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Viral Vector CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Viral Vector CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Viral Vector CDMO Services Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Viral Vector CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Viral Vector CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Viral Vector CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 49. Thermo Fisher Scientific Company Details
Table 50. Thermo Fisher Scientific Business Overview
Table 51. Thermo Fisher Scientific Viral Vector CDMO Services Product
Table 52. Thermo Fisher Scientific Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 53. Thermo Fisher Scientific Recent Development
Table 54. Lonza Company Details
Table 55. Lonza Business Overview
Table 56. Lonza Viral Vector CDMO Services Product
Table 57. Lonza Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 58. Lonza Recent Development
Table 59. Catalent Company Details
Table 60. Catalent Business Overview
Table 61. Catalent Viral Vector CDMO Services Product
Table 62. Catalent Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 63. Catalent Recent Development
Table 64. Charles River Company Details
Table 65. Charles River Business Overview
Table 66. Charles River Viral Vector CDMO Services Product
Table 67. Charles River Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 68. Charles River Recent Development
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Viral Vector CDMO Services Product
Table 72. Merck Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 73. Merck Recent Development
Table 74. SK pharmteco Company Details
Table 75. SK pharmteco Business Overview
Table 76. SK pharmteco Viral Vector CDMO Services Product
Table 77. SK pharmteco Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 78. SK pharmteco Recent Development
Table 79. Oxford Biomedica Company Details
Table 80. Oxford Biomedica Business Overview
Table 81. Oxford Biomedica Viral Vector CDMO Services Product
Table 82. Oxford Biomedica Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 83. Oxford Biomedica Recent Development
Table 84. AGC Biologics（MolMed） Company Details
Table 85. AGC Biologics（MolMed） Business Overview
Table 86. AGC Biologics（MolMed） Viral Vector CDMO Services Product
Table 87. AGC Biologics（MolMed） Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 88. AGC Biologics（MolMed） Recent Development
Table 89. Gene Universal Company Details
Table 90. Gene Universal Business Overview
Table 91. Gene Universal Viral Vector CDMO Services Product
Table 92. Gene Universal Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 93. Gene Universal Recent Development
Table 94. Polyplus (Sartorius) Company Details
Table 95. Polyplus (Sartorius) Business Overview
Table 96. Polyplus (Sartorius) Viral Vector CDMO Services Product
Table 97. Polyplus (Sartorius) Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 98. Polyplus (Sartorius) Recent Development
Table 99. CCRM Company Details
Table 100. CCRM Business Overview
Table 101. CCRM Viral Vector CDMO Services Product
Table 102. CCRM Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 103. CCRM Recent Development
Table 104. FUJIFILM Diosynth Biotechnologies Company Details
Table 105. FUJIFILM Diosynth Biotechnologies Business Overview
Table 106. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product
Table 107. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 108. FUJIFILM Diosynth Biotechnologies Recent Development
Table 109. Biovian Company Details
Table 110. Biovian Business Overview
Table 111. Biovian Viral Vector CDMO Services Product
Table 112. Biovian Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 113. Biovian Recent Development
Table 114. Miltenyi Bioindustry Company Details
Table 115. Miltenyi Bioindustry Business Overview
Table 116. Miltenyi Bioindustry Viral Vector CDMO Services Product
Table 117. Miltenyi Bioindustry Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 118. Miltenyi Bioindustry Recent Development
Table 119. Aldevron Company Details
Table 120. Aldevron Business Overview
Table 121. Aldevron Viral Vector CDMO Services Product
Table 122. Aldevron Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 123. Aldevron Recent Development
Table 124. Takara Bio Company Details
Table 125. Takara Bio Business Overview
Table 126. Takara Bio Viral Vector CDMO Services Product
Table 127. Takara Bio Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 128. Takara Bio Recent Development
Table 129. Yposkesi Company Details
Table 130. Yposkesi Business Overview
Table 131. Yposkesi Viral Vector CDMO Services Product
Table 132. Yposkesi Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 133. Yposkesi Recent Development
Table 134. Genezen Company Details
Table 135. Genezen Business Overview
Table 136. Genezen Viral Vector CDMO Services Product
Table 137. Genezen Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 138. Genezen Recent Development
Table 139. GenScript ProBio Company Details
Table 140. GenScript ProBio Business Overview
Table 141. GenScript ProBio Viral Vector CDMO Services Product
Table 142. GenScript ProBio Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 143. GenScript ProBio Recent Development
Table 144. EurekaBio Company Details
Table 145. EurekaBio Business Overview
Table 146. EurekaBio Viral Vector CDMO Services Product
Table 147. EurekaBio Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 148. EurekaBio Recent Development
Table 149. Obio Technology Company Details
Table 150. Obio Technology Business Overview
Table 151. Obio Technology Viral Vector CDMO Services Product
Table 152. Obio Technology Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 153. Obio Technology Recent Development
Table 154. GeneSail Biotech Company Details
Table 155. GeneSail Biotech Business Overview
Table 156. GeneSail Biotech Viral Vector CDMO Services Product
Table 157. GeneSail Biotech Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 158. GeneSail Biotech Recent Development
Table 159. VectorBuilder Company Details
Table 160. VectorBuilder Business Overview
Table 161. VectorBuilder Viral Vector CDMO Services Product
Table 162. VectorBuilder Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 163. VectorBuilder Recent Development
Table 164. WuXi ATU Company Details
Table 165. WuXi ATU Business Overview
Table 166. WuXi ATU Viral Vector CDMO Services Product
Table 167. WuXi ATU Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 168. WuXi ATU Recent Development
Table 169. Ubrigene Company Details
Table 170. Ubrigene Business Overview
Table 171. Ubrigene Viral Vector CDMO Services Product
Table 172. Ubrigene Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 173. Ubrigene Recent Development
Table 174. Porton Biologics Company Details
Table 175. Porton Biologics Business Overview
Table 176. Porton Biologics Viral Vector CDMO Services Product
Table 177. Porton Biologics Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 178. Porton Biologics Recent Development
Table 179. Pharmaron Company Details
Table 180. Pharmaron Business Overview
Table 181. Pharmaron Viral Vector CDMO Services Product
Table 182. Pharmaron Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 183. Pharmaron Recent Development
Table 184. PackGene Biotechnology Company Details
Table 185. PackGene Biotechnology Business Overview
Table 186. PackGene Biotechnology Viral Vector CDMO Services Product
Table 187. PackGene Biotechnology Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 188. PackGene Biotechnology Recent Development
Table 189. Hillgene Company Details
Table 190. Hillgene Business Overview
Table 191. Hillgene Viral Vector CDMO Services Product
Table 192. Hillgene Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 193. Hillgene Recent Development
Table 194. Asymchem Company Details
Table 195. Asymchem Business Overview
Table 196. Asymchem Viral Vector CDMO Services Product
Table 197. Asymchem Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 198. Asymchem Recent Development
Table 199. Exthera Company Details
Table 200. Exthera Business Overview
Table 201. Exthera Viral Vector CDMO Services Product
Table 202. Exthera Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 203. Exthera Recent Development
Table 204. Flash Therapeutics Company Details
Table 205. Flash Therapeutics Business Overview
Table 206. Flash Therapeutics Viral Vector CDMO Services Product
Table 207. Flash Therapeutics Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 208. Flash Therapeutics Recent Development
Table 209. VIVEBiotech Company Details
Table 210. VIVEBiotech Business Overview
Table 211. VIVEBiotech Viral Vector CDMO Services Product
Table 212. VIVEBiotech Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 213. VIVEBiotech Recent Development
Table 214. FinVector Company Details
Table 215. FinVector Business Overview
Table 216. FinVector Viral Vector CDMO Services Product
Table 217. FinVector Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 218. FinVector Recent Development
Table 219. uBriGene Company Details
Table 220. uBriGene Business Overview
Table 221. uBriGene Viral Vector CDMO Services Product
Table 222. uBriGene Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 223. uBriGene Recent Development
Table 224. Eurogentec Company Details
Table 225. Eurogentec Business Overview
Table 226. Eurogentec Viral Vector CDMO Services Product
Table 227. Eurogentec Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 228. Eurogentec Recent Development
Table 229. VGXI Company Details
Table 230. VGXI Business Overview
Table 231. VGXI Viral Vector CDMO Services Product
Table 232. VGXI Revenue in Viral Vector CDMO Services Business (2020-2025) & (US$ Million)
Table 233. VGXI Recent Development
Table 234. Research Programs/Design for This Report
Table 235. Key Data Information from Secondary Sources
Table 236. Key Data Information from Primary Sources
Table 237. Authors List of This Report


List of Figures
Figure 1. Viral Vector CDMO Services Picture
Figure 2. Global Viral Vector CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Vector CDMO Services Market Share by Type: 2024 VS 2031
Figure 4. AAV Features
Figure 5. Lentivirus Features
Figure 6. Adenovirus Features
Figure 7. HSV Features
Figure 8. Others Features
Figure 9. Global Viral Vector CDMO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Viral Vector CDMO Services Market Share by Application: 2024 VS 2031
Figure 11. Vaccine Development Case Studies
Figure 12. Gene Therapy Case Studies
Figure 13. Academic Scientific Research Institution Case Studies
Figure 14. Others Case Studies
Figure 15. Viral Vector CDMO Services Report Years Considered
Figure 16. Global Viral Vector CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Viral Vector CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Viral Vector CDMO Services Market Share by Region: 2024 VS 2031
Figure 19. Global Viral Vector CDMO Services Market Share by Players in 2024
Figure 20. Global Top Viral Vector CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector CDMO Services as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Viral Vector CDMO Services Revenue in 2024
Figure 22. North America Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Viral Vector CDMO Services Market Share by Country (2020-2031)
Figure 24. United States Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Viral Vector CDMO Services Market Share by Country (2020-2031)
Figure 28. Germany Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Viral Vector CDMO Services Market Share by Region (2020-2031)
Figure 36. China Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Viral Vector CDMO Services Market Share by Country (2020-2031)
Figure 44. Mexico Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Viral Vector CDMO Services Market Share by Country (2020-2031)
Figure 48. Turkey Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Viral Vector CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 53. Catalent Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 54. Charles River Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 56. SK pharmteco Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 57. Oxford Biomedica Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 58. AGC Biologics（MolMed） Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 59. Gene Universal Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 60. Polyplus (Sartorius) Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 61. CCRM Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 62. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 63. Biovian Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 64. Miltenyi Bioindustry Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 65. Aldevron Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 66. Takara Bio Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 67. Yposkesi Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 68. Genezen Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 69. GenScript ProBio Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 70. EurekaBio Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 71. Obio Technology Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 72. GeneSail Biotech Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 73. VectorBuilder Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 74. WuXi ATU Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 75. Ubrigene Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 76. Porton Biologics Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 77. Pharmaron Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 78. PackGene Biotechnology Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 79. Hillgene Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 80. Asymchem Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 81. Exthera Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 82. Flash Therapeutics Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 83. VIVEBiotech Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 84. FinVector Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 85. uBriGene Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 86. Eurogentec Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 87. VGXI Revenue Growth Rate in Viral Vector CDMO Services Business (2020-2025)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit